IBD International Genetics Consortium: international cooperation making sense of complex disease.
The Inflammatory Bowel Disease International Genetic Consortium was formed in Oxford in 1997. Since then it has grown to include twelve groups from around the world that are each actively involved in identifying the genes that are involved in susceptibility to IBD. The approach of the IBDIGC is to attempt to overcome one of the major issues in complex disease analysis-that of obtaining sufficient power to analyze successfully the inheritance of IBD-by collaboratively studying large numbers of well documented families with multiple affected individuals. This strategy has been marked by considerable success with the publication of a paper authored by the IBDIGC substantiating the localization of IBD1 to chromosome 16. This publication served to encourage researchers and eventually resulted in the identification by several groups simultaneously of risk alleles in the NOD2 gene that cosegregate with disease. The IBDIGC provides a model for studies in complex disease genetics, showing that research groups both large and small can participate equally in complex disease gene identification through the formation of large international consortia.
Cavanaugh
Juleen A
JA
Medical Genetics Unit, Australian National University Medical School, Canberra ACT, Australia. Juleen.Cavanaugh@anu.edu.au
D003226:Congresses as Topic / Q000458:organization & administration; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000235:genetics*; D010375:Pedigree; D012042:Registries